

In this audio interview conducted on June 3, 2020, the editors discuss two new studies: one comparing test swabs collected by health care workers with swabs collected by the patients themselves and one assessing hydroxychloroquine treatment in people who had been exposed to Covid-19 but weren’t yet ill.
The continuing spread of SARS-CoV-2 remains a Public Health Emergency of International Concern. What physicians need to know about transmission, diagnosis, and treatment of Covid-19 is the subject of ongoing updates from infectious disease experts at the Journal.
Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving too quickly.
WSJ’s Daniela Hernandez explains. Photo illustration: Laura Kammermann
A selection of three essential articles read aloud from the latest issue of The Economist. This week, how the world’s most powerful country is handling covid-19, China’s decision to impose a security law on Hong Kong threatens a broader reckoning (10:04). And why mercenaries are still hired by African governments (18:30).
Originating during the Black Death of the Middle Ages, face coverings to protect against the transmission of disease are not just medical requirements; they’re now a fashion statement. Mark Phillips talks with medical historian Mark Honigsbaum (“The Pandemic Century”) about the purpose and style of facemasks.
President Trump’s preferred coronavirus treatment is the focus of a new study suggesting it could cause more harm than good, but not everybody agrees. We discuss the fallout as trials around the world are paused and countries diverge over policy advice.
12:12 Are we rushing science?
Coronavirus papers are being published extremely quickly, while normally healthy scientific debate is being blown up in the world’s press. Is there a balancing act between timely research and accurate messaging?
18:49 One good thing
Our hosts pick out things that have made them smile in the last week, including hedgerow brews and a trip into the past using AI.
Recipe: Elderflower ‘Champagne’
Video: Denis Shiryaev restores historic footage with AI
22:30 The latest coronavirus research papers
Noah Baker takes a look through some of the key coronavirus papers of the last few weeks.
News: Coronavirus research updates
medRxiv: Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel
Harvard Library: Reductions in commuting mobility predict geographic differences in SARS-CoV-2 prevalence in New York City
Science: DNA vaccine protection against SARS-CoV-2 in rhesus macaques
A bar in the Swiss Alps. A megachurch in South Korea. Scientists are focusing on certain superspreading events that might be responsible for an outsized portion of coronavirus cases.Bojan Pancevski explains how this understanding could be key to reopening.
The first results from vaccine trials are in and they are encouraging, but scientists are still urging caution. We hear the lowdown on the types of vaccines being developed and what hope there is of rolling them out any time soon.
01:38 Trump vs the WHO
President Trump has given the WHO an ultimatum in a tweet, threatening to pull out of the organisation within 30 days unless unclear demands are met. We discuss what this means for the pandemic, the USA and the future of international health cooperation
12:06 Where are we with vaccines?
The first results from vaccine trials are in and they are encouraging, but scientists are still urging caution. We hear the lowdown on the types of vaccines being developed and what hope there is of rolling them out any time soon.
News: Coronavirus vaccine trials have delivered their first results — but their promise is still unclear
News: The race for coronavirus vaccines: a graphical guide
News: If a coronavirus vaccine arrives, can the world make enough?
25:20 One good thing
Our hosts pick out things that have made them smile in the last week, including hopeful antibody research, at-home sketch comedy and printable board games.
News: Potent human antibodies could inspire a vaccine
Video: Whiskers R we – SNL
Video:The wild affordable world of 1 Player Print’n’Play Games
Video:MORE of the Very Best Solitaire Print’n’Play Games
Video: Marble run league
Video: BBC goals at home (Only available in the UK)
30:04 The latest coronavirus research papers
Noah Baker takes a look through some of the key coronavirus papers of the last few weeks.
News: Coronavirus research updates
medRxiv: Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharangel swabs
Nature: Effect of non-pharmaceutical interventions to contain COVID-19 in China
Science: Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China
New England Journal of Medicine:
Online News Editor David Grimm talks with producer Joel Goldberg about the unique challenges of reopening labs amid the coronavirus pandemic. Though the chance to resume research may instill a sense of hope, new policies around physical distancing and access to facilities threaten to derail studies—and even careers.
Despite all the uncertainty, the crisis could result in new approaches that ultimately benefit the scientific community and the world. Also this week, Joel Podgorski, a senior scientist in the Water Resources and Drinking Water Department at the Swiss Federal Institute of Aquatic Science and Technology, joins host Sarah Crespi to discuss the global threat of arsenic in drinking water. Arsenic is basically present in all rocks in minute amounts. Under the right conditions it can leach into groundwater and poison drinking water. Without a noticeable taste or smell, arsenic contamination can go undetected for years. The paper, published in Science, estimates that more than 100 million people are at risk of drinking arsenic-contaminated water and provides a guide for the most important places to test.